Mednax Inc Stock News

Shares of Mednax (NYSE:MD) were flat in pre-market trading after the company reported Q2 results.Quarterly Results Earnings per share were down 64.04% over the past year to $0.32, which may not compar

Mednax (MD) delivered earnings and revenue surprises of 113.33% and -13.83%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

MEDNAX Reports Second Quarter Results Results from Continuing Operations Reflect Significant Recovery in Second Half of Quarter Following Initial Disr

Companies Reporting Before The Bell • Mastercard Inc. (NYSE:MA) is expected to report quarterly earnings at $1.16 per share on revenue of $3.23 billion. • Moody's...

Mednax (MD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Starboard Value increased its position in pediatric and neonatal health-services firm Mednax. Carrick Management Partners disclosed an initial investment of 3,508,278 shares in Accolade, a newly publi

Jefferson Radiology Announces Implementation of iCAD ProFound AI™ Platform Across its Enterprise.

MEDNAX 2020 Second Quarter Conference Call/Webcast Scheduled for Thursday, July 30, 2020

Healthcare services company Mednax's stock price closed up nearly 4% on Monday after its founder and chief executive and several board members were replaced, half a year after activist investor Starbo

Healthcare services company Mednax's stock price closed up nearly 4% on Monday after its founder and chief executive and several board members were replaced, half a year after activist investor Starb

Mednax CEO, board directors replaced amid settlement with Starboard

Pressure from the COVID-19 impact on global economy and lack of solvency make MEDNAX (MD) an unattractive bet.

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and succes

MEDNAX Announces Leadership and Board Transitions Mark S. Ordan Appointed Chief Executive Officer, Succeeding Company Founder Roger J. Medel, M.D.

MEDNAX Announces Leadership and Board Transitions Mark S. Ordan Appointed Chief Executive Officer, Succeeding Company Founder Roger J. Medel, M.D.